All News
1st Line Biologics vs csDMARDs in Adult Still's Disease
A German multicentre, retrospective study assessed the first-line efficacy of biologics and conventional synthetic DMARD therapy in patients with adult-onset Still's disease and found biologic agents were significantly better with sustained, event-free remissions and fewer complications.
Read Article
Consensus Against Interventional Injections for Chronic Spinal Pain
BMJ has published a clinical practice guideline resulting from the work of an international, multidisciplinary panel addressing chronic spine pain (≥3 months duration) not associated with cancer or inflammatory arthropathy.
Consensus on Bone Turnover Biomarkers in Osteoporosis
d
EurekAlert!
A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis Foundation (IOF), and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC),
Read Article
Patient Education handout on Raynaud’s Phenomenon https://t.co/Ug2MmtexgU https://t.co/kk9Klxhl8x
Dr. John Cush RheumNow ( View Tweet)
A study in Alberta, Canada, examining the travel burdens for rheumatoid arthritis patients, found a median travel time of 13 minutes to reach general practitioners and 34 minutes to see rheumatologists. The research highlighted significant disparities between rural and urban https://t.co/2kYDrk16O8
Dr. John Cush RheumNow ( View Tweet)
Obstacles to the current use of DMARDs from patients, discussed during regular appointments, were mainly associated with adverse effects and worries about effectiveness and long-term usage. Ongoing attention to these patients' concerns is crucial for improving treatment https://t.co/hWYGiPIsBb
Dr. John Cush RheumNow ( View Tweet)
Diagnosing PMR is easy before Pred initiation; but after steroids NO SO. Before Pred, PMR Dx from non-PMR (median probabilities 7.8 vs 2.8) w/ 86% sensitivity/83% specificity. After Pred Dx probability of PMR dropped to 1.0 w/ sensitivity 3.5%; not much better w/ Pred D/C https://t.co/q4TceeFByc
Dr. John Cush RheumNow ( View Tweet)
Repetitive Transcranial Magnetic Stimulation in Fibromyalgia
A randomized, sham-controlled trial has shown that repetitive transcranial magnetic stimulation (rTMS) reduced pain in fibromyalgia for up to 8 weeks; while analgesic effects waned, functional improvements remained https://t.co/nJdSrUcizo
Dr. John Cush RheumNow ( View Tweet)
Cardiac-MSK Patients at Highest Risk for Falls and Death
A study by Peking University and Chinese PLA General Hospital found that multimorbidity, having multiple chronic diseases, is linked to worsening falls and higher mortality in middle-aged and older adults in China. https://t.co/R47w77zSwP
Dr. John Cush RheumNow ( View Tweet)
Patient Education handout on Carpal Tunnel Syndrome https://t.co/QwgZ8Jr7GQ https://t.co/wtg324nzlo
Links:
Dr. John Cush RheumNow ( View Tweet)
Diagnosing PMR is easy before Pred initiation; but after steroids NO SO. Before Pred, PMR Dx from non-PMR (median probabilities 7.8 vs 2.8) w/ 86% sensitivity/83% specificity. After Pred Dx probability of PMR dropped to 1.0 w/ sensitivity 3.5%; not much better w/ Pred D/C https://t.co/RRIYY6xleN
Dr. John Cush RheumNow ( View Tweet)
Barriers to current DMARD use from pts, discussed during routine visits were primarily related to side effects and concerns about the efficacy and long-term use. Continuous attention to these patients’ concerns are key to better treatment adherence https://t.co/J0kPR2CQyH https://t.co/D84t4dPdLO
Links:
Dr. John Cush RheumNow ( View Tweet)
Patient Education handout on Raynaud’s Phenomenon https://t.co/cm77mmmPSi https://t.co/GimQXHBdpp
Dr. John Cush RheumNow ( View Tweet)
“Medicine is a science of uncertainty and an art of probability.” - Sir William Osler https://t.co/SQH3JZcDfv
Dr. John Cush RheumNow ( View Tweet)
Targeting Obesity in Rheumatic Disease Patients
Sattar et al. has published an informative overview of the effect of obesity on rheumatic and musculoskeletal diseases (RMDs). They estimate that nearly 70% of RMD patients are overweight or obese.
https://t.co/OYtsbfJQ2e https://t.co/xEZI3mkY0q
Dr. John Cush RheumNow ( View Tweet)
Disease activity during Pregnancy in Rheumatoid arthritis and Spondyloarthritis
A prospective French study of rheumatoid arthritis (RA) or spondyloarthritis (SpA) patients showed that most maintained stable disease activity during pregnancy, but over one-third flared and https://t.co/MaWx6AZ0JF
Dr. John Cush RheumNow ( View Tweet)
Increasing Prevalence of Osteoporosis
Research published in Osteoporosis International studied NHANES data showed increasing trends in osteoporosis in the United States of America.
https://t.co/KHWdMgjG0P https://t.co/lfXZA9F2JX
Dr. John Cush RheumNow ( View Tweet)
Autoimmune Disease Impact Report
Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: https://t.co/x3l9HIDul8
Dr. John Cush RheumNow ( View Tweet)
NP and PA Growth in the USA
Forbes has published a thoughtful perspective on the declining number of US physicians and the growth in the number of advanced practice providers or APPs in the US clinical workforce.
https://t.co/3Am8ZfEFo1 https://t.co/HeYfHc03Lu https://t.co/6H5wuf5RJ0
Dr. John Cush RheumNow ( View Tweet)
In 2021 the global rheumatoid arthritis market was valued at USD 22.77 billion and is expected to reach USD 33.30 billion by 2030. https://t.co/0vU6QP9JiG https://t.co/a8jXwk3KbK
Links:
Dr. John Cush RheumNow ( View Tweet)
